BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

397 related articles for article (PubMed ID: 3508039)

  • 1. HLA antigens and susceptibility to myasthenia gravis.
    Matej H; Nowakowska B; Kałamarz M; Paradowski B; Podemski R; Brzecki A
    Arch Immunol Ther Exp (Warsz); 1987; 35(6):795-801. PubMed ID: 3508039
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HLA genotypes in Turkish patients with myasthenia gravis: comparison with multiple sclerosis patients on the basis of clinical subtypes and demographic features.
    Dönmez B; Ozakbas S; Oktem MA; Gedizlioglu M; Coker I; Genc A; Idiman E
    Hum Immunol; 2004 Jul; 65(7):752-7. PubMed ID: 15301866
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [HLA and myasthenia. Subdivision in 3 categories].
    Elchidiac A; Lepage V; Berrih S; Colombani J; Degos L
    Pathol Biol (Paris); 1985 Jan; 33(1):50-4. PubMed ID: 3871932
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Susceptibility to autoimmune chronic active hepatitis: human leukocyte antigens DR4 and A1-B8-DR3 are independent risk factors.
    Donaldson PT; Doherty DG; Hayllar KM; McFarlane IG; Johnson PJ; Williams R
    Hepatology; 1991 Apr; 13(4):701-6. PubMed ID: 2010165
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The HLA-DR phenotype in Croatian children with gluten enteropathy].
    Jurcić Z; Brkljacić-Surkalović L; Kerhin-Brkljacić V; Kastelan A; Miskić-Musa M; Zobenica M; Pavlović S
    Lijec Vjesn; 1998 Sep; 120(9):273-7. PubMed ID: 10099667
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [HLA typing and insulin antibody production in insulin-dependent diabetics].
    Bruni B; Barolo P; Gadaleta G; Gamba Ansaldi S; Grassi G; Zerbinati A; Molinatti M; Salvetti E
    Ann Osp Maria Vittoria Torino; 1984; 27(7-12):185-213. PubMed ID: 6443704
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HLA as an immunogenetic risk factor in juvenile chronic arthritis.
    Matej H; Kałamarz M; Nowakowska B; Prusek W; Podwysocka M; Wieczorek E; Zahorska Z
    Arch Immunol Ther Exp (Warsz); 1987; 35(6):787-94. PubMed ID: 3508038
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HLA A, B, and DR antigens and complotype in Tunisian patients with diabetes mellitus.
    Ayed K; Bardi R; Gorgi Y; Jenhani F; Chammakhi S; Boukhris R
    Dis Markers; 1989; 7(1):43-7. PubMed ID: 2714046
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Subgroups of myasthenia gravis. Association of the early form with HLA B8/DR3].
    Scherbaum WA; Schumm F
    Dtsch Med Wochenschr; 1983 Aug; 108(31-32):1218. PubMed ID: 6575909
    [No Abstract]   [Full Text] [Related]  

  • 10. HLA class II antigens and DNA restriction fragment length polymorphism in myasthenia gravis in Japan.
    Morita K; Moriuchi J; Inoko H; Tsuji K; Arimori S
    Ann Neurol; 1991 Feb; 29(2):168-74. PubMed ID: 1672809
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antiacetylcholine receptor and antinuclear antibodies in myasthenia gravis. Correlation with HLA, sex and Gm.
    Warlow RS; Garlepp M; Feeney D; Kay P; Swanson N; Dawkins RL
    Exp Clin Immunogenet; 1985; 2(3):158-63. PubMed ID: 3917146
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Immunogenetics of myasthenia gravis. Significance of HLA-, complement and Cm gene systems for clinical and immunologic parameters].
    Grosse-Wilde H; Toyka KV; Besinger UA; Doxiadis I; Heininger K; Hömberg M; Hömberg V; Hohlfeld R; Fateh-Moghadam A; Jungwirth J; Kreeb G; Vögeler U
    Dtsch Med Wochenschr; 1983 May; 108(18):694-700. PubMed ID: 6839994
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HLA antigens in systemic lupus erythematosus: relationship to disease severity, age at onset, and sex.
    Bell DA; Rigby R; Stiller CR; Clark WF; Harth M; Ebers G
    J Rheumatol; 1984 Aug; 11(4):475-9. PubMed ID: 6332909
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correlation of thymic pathology with HLA in myasthenia gravis.
    Machens A; Löliger C; Pichlmeier U; Emskötter T; Busch C; Izbicki JR
    Clin Immunol; 1999 Jun; 91(3):296-301. PubMed ID: 10370374
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HLA type is not indicative for the effect of thymectomy in myasthenia gravis.
    Kuks JB; Lems SP; Oosterhuis HJ
    J Neuroimmunol; 1992 Feb; 36(2-3):217-24. PubMed ID: 1732282
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Antigens of histocompatibility in children with myasthenia gravis].
    Neretin VIa; Serova LD; Agafonov BV; Tsuman VG; Gekht BM; Sidorova OP; Nalivkin AE
    Zh Nevrol Psikhiatr Im S S Korsakova; 2001; 101(7):44-8. PubMed ID: 11523395
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HLA in Singapore Chinese with rheumatoid arthritis.
    Boey ML; Wee GB; Mohan C; Howe HS; Chan SH; Feng PH
    J Rheumatol; 1992 Oct; 19(10):1517-9. PubMed ID: 1464861
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Studies on HLA antigens and cellular and humoral autoimmune phenomena in patients with myasthenia gravis.
    Gross WL; Krüger J; Gröschel-Stewart U; Friedrich H; Kunze K
    Clin Exp Immunol; 1977 Jan; 27(1):48-54. PubMed ID: 849650
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [A new HLA-B antigen: HLA-Bw 59].
    Nakai Y
    Hokkaido Igaku Zasshi; 1984 Sep; 59(5):614-21. PubMed ID: 6210236
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Strong association of MuSK antibody-positive myasthenia gravis and HLA-DR14-DQ5.
    Niks EH; Kuks JB; Roep BO; Haasnoot GW; Verduijn W; Ballieux BE; De Baets MH; Vincent A; Verschuuren JJ
    Neurology; 2006 Jun; 66(11):1772-4. PubMed ID: 16769963
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.